North Star Investment Management’s Array Biopharma Inc ARRY Stock Holding History

North Star Investment Management’s Portfolio ARRY Stock Details ARRY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-100,000	Closed	-$4.63M	–	1124
2019 Q2	$4.63M	Hold	100,000	–	–	0.54%	42
2019 Q1	$2.44M	Hold	100,000	–	–	0.28%	100
2018 Q4	$1.43M	Hold	100,000	–	–	0.19%	143
2018 Q3	$1.52M	Hold	100,000	–	–	0.17%	161
2018 Q2	$1.68M	Buy	100,000 +30,000	+43%	+$477K	0.19%	146
2018 Q1	$1.14M	Buy	70,000 +7,000	+11%	+$112K	0.14%	193
2017 Q4	$806K	Buy	63,000 +13,000	+26%	+$148K	0.1%	213
2017 Q3	$615K	Hold	50,000	–	–	0.08%	232
2017 Q2	$418K	Hold	50,000	–	–	0.06%	270
2017 Q1	$447K	Buy	50,000 +40,000	+400%	+$426K	0.06%	257
2016 Q4	$88K	Buy	+10,000	New	+$73.6K	0.01%	410

Other funds holding ARRY

ASN

Advisory Services Network Atlanta, Georgia $7.52B AUM 29.01% 1-Year Est. Return

North Star Investment Management's ARRY Position: Q3 2019 in Review

North Star Investment Management sold out of Array Biopharma Inc (ARRY) in Q3 2019, closing a stake of 100,000 shares — an estimated $4.63M sold.

North Star Investment Management first reported a position in ARRY in Q4 2016 and held it in 11 quarters. The position peaked at $4.63M in Q2 2019. 1 fund tracked by Wall St. Rank holds ARRY as of Q3 2019.

North Star Investment Management reported no remaining Array Biopharma Inc position as of Q3 2019 after selling out during the quarter.
North Star Investment Management sold 100,000 Array Biopharma Inc shares in Q3 2019, an estimated $4.63M.
North Star Investment Management first reported a position in Array Biopharma Inc in Q4 2016 and held it in 11 quarters.
North Star Investment Management's Array Biopharma Inc position peaked at $4.63M in Q2 2019.
1 fund tracked by Wall St. Rank held Array Biopharma Inc as of Q3 2019.

Based on North Star Investment Management's 13F filing for Q3 2019, filed 3 Oct 2019.